Biotech

All Articles

Vir increases 3 T-cell engagers coming from Sanofi, lays off 25% of workers

.Vir Medical's second-quarter incomes record had not been except major updates. The provider invited...

Galapagos stops CAR-T tissue therapy trial over Parkinsonism case

.Galapagos has stopped registration in a trial of a BCMA-directed CAR-T cell treatment, pumping the ...

James Wilson leaving Penn to release 2 brand-new biotechs

.After much more than thirty years, genetics therapy pioneer James Wilson M.D., Ph.D., is leaving be...

3 biotechs make an effort to trump the summer heat energy through dropping staff

.As biotechs try to turn a fresh web page in August, a minimum of 3 companies have actually lost tea...

venBio elevates $528M for fifth life scientific researches VC fund

.Professional equity capital company venBio has raised yet another half a billion dollars to invest ...

Otsuka spends $800M for Jnana and also its own clinical-stage PKU medication

.Otsuka Pharmaceutical has actually picked up Boston-based Jnana Therapeutics for $800 thousand so t...

FibroGen gives up 75% of US staff as asset fails 2 additional tests

.FibroGen is actually drastically restructuring its business, giving up 75% of its own U.S. team and...

Tracon unwind weeks after injectable PD-L1 prevention fail

.Tracon Pharmaceuticals has decided to wind down procedures weeks after an injectable invulnerable g...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is actually betting $400 thousand in biobucks that a bispecific antibody-drug co...

Takeda takes $140M reduction on failed epilepsy medicine, touts FDA operate

.We already recognize that Takeda is actually expecting to find a path to the FDA for epilepsy medic...